Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clonal Hematopoiesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06817590
What this trial is testing

Nucleoside Therapy in Patients With Telomere Biology Disorders

Who this might be right for
Telomere Biology DisordersDyskeratosis CongenitaRevesz Syndrome+4 more
Suneet Agarwal 36
Testing effectiveness (Phase 2)Looking for participantsNCT06691217
What this trial is testing

Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis

Who this might be right for
Vascular InflammationASCVDASCVD Management
Massachusetts General Hospital 120
Not applicableNot Yet RecruitingNCT07615023
What this trial is testing

Clonal Hematopoiesis of Indeterminate Potential and Infarct Severity in ST-Elevation Myocardial Infarction

Who this might be right for
ST-elevation Myocardial Infarction (STEMI)Clonal Hematopoiesis of Indeterminate Potential (CHIP)
Medical University Innsbruck 350
Post-approval studies (Phase 4)Looking for participantsNCT07362966
What this trial is testing

Precision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis

Who this might be right for
ColchicineCoronary Atherosclerosis ManagementClonal Hematopoiesis of Indeterminate Potential
Shenyang Northern Hospital 120
Not applicableLooking for participantsNCT07500441
What this trial is testing

Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Peking University People's Hospital 100
Not applicableStudy completedNCT04987268
What this trial is testing

CHIP and Residual Cardiovascular Event Tendency After Smoking Cessation

Who this might be right for
ACSClonal Hematopoiesis of Indeterminate PotentialSmoking Cessation
Shenyang Northern Hospital 1,029
Not applicableLooking for participantsNCT06870760
What this trial is testing

Pre-malignant States to Hematologic Malignancies in Firefighters

Who this might be right for
Clonal Hematopoiesis of Indeterminate PotentialMonoclonal GammopathyNon Hodgkin Lymphoma+3 more
Wake Forest University Health Sciences 300
Not applicableLooking for participantsNCT04053439
What this trial is testing

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

Who this might be right for
LymphomaChemotherapeutic Toxicity
Sunnybrook Health Sciences Centre 188
Not applicableNot Yet RecruitingNCT05969821
What this trial is testing

Clonal Hematopoiesis of Immunological Significance

Who this might be right for
Immune System DiseasesAutoimmune DiseasesInflammation+13 more
Assistance Publique - Hôpitaux de Paris 5,000
Not applicableLooking for participantsNCT06626685
What this trial is testing

Clonal Hematopoiesis of Indeterminate Potential in Heart Failure.

Who this might be right for
Heart Failure
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 300
Not applicableLooking for participantsNCT02958462
What this trial is testing

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Who this might be right for
Myeloid MalignancyInherited Bone Marrow Failure SyndromeClonal Expansion+10 more
Mayo Clinic 2,000
Early research (Phase 1)Looking for participantsNCT07188740
What this trial is testing

Metformin Inhibits DNMT3A Clonal Hematopoiesis in Acute Leukemia

Who this might be right for
DNMT3A Gene Mutation
Institute of Hematology & Blood Diseases Hospital, China 32
Not applicableStudy completedNCT00003095
What this trial is testing

S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 26
Not applicableStudy completedNCT07746986
What this trial is testing

DECIPHERING AND TARGETING VEXAS

Who this might be right for
VEXAS
IRCCS San Raffaele 60
Not applicableLooking for participantsNCT05711173
What this trial is testing

Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)

Who this might be right for
Venous ThrombosesThromboembolic DiseaseNeutrophil Extracellular Trap Formation+1 more
University Hospital, Bordeaux 150
Not applicableStudy completedNCT05146414
What this trial is testing

Clonal Hematopoiesis of Indeterminate Potential and Accelerated Atherosclerosis in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Assistance Publique - Hôpitaux de Paris 500
Not applicableLooking for participantsNCT07313059
What this trial is testing

CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research

Who this might be right for
Clonal HematopoiesisCCUS Clonal Cytopenia of Undetermined SignificanceHematologic Disease and Disorders
Clinical Hub for Interventional Research (CHOIR) 100
Not applicableLooking for participantsNCT06295965
What this trial is testing

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+7 more
University of Washington 2,000
Testing effectiveness (Phase 2)Study completedNCT06097663
What this trial is testing

Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Who this might be right for
Coronary Heart DiseaseClonal Hematopoiesis of Indeterminate Potential (CHIP)
Novartis Pharmaceuticals 31
Not applicableUnknownNCT03682029
What this trial is testing

Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic Leukemia-1Cytopenia
Rigshospitalet, Denmark 109
Next Page